SCHEMBL6289829

SCHEMBL6289829

CN(C)c1ccccc1P

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
MAPT P10636 4/20 0.44
GAA P10253 4/20 0.44
TSHR P16473 3/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 2/20 0.44
CHEK1 O14757 1/20 0.43
NEK2 P51955 1/20 0.43
LIMK1 P53667 1/20 0.43
DYRK1A Q13627 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
HTR6 P50406 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
NSD2 O96028 1/20 0.39
EGFR P00533 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
EP300 Q09472 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366889 0.80 MAPT (0.42) ALDH1A1MAPTGAATSHRTP53
SCHEMBL26631046 0.79 MAPT (0.46) ALDH1A1MAPTGAATSHRTP53
SCHEMBL65263 0.78 MAPT (0.55) ALDH1A1MAPTGAATSHRTP53
SCHEMBL4588436 0.77 MAPT (0.44) ALDH1A1MAPTGAATSHRTP53
SCHEMBL18922435 0.77 MAPT (0.53) ALDH1A1MAPTGAATSHRTP53
SCHEMBL15658498 0.75 MAPT (0.47) ALDH1A1MAPTGAATSHRTP53
Cyclohexane SCHEMBL3588452 0.75 MAPT (0.39) ALDH1A1MAPTGAATSHRTP53
SCHEMBL3184967 0.72 MAPT (0.44) ALDH1A1MAPTGAATSHRTP53
SCHEMBL28806634 0.72 ALDH1A1 (0.44) ALDH1A1MAPTGAATSHRTP53
SCHEMBL27997994 0.72 TSHR (0.39) ALDH1A1MAPTGAATSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108659534-A Building template material and preparation method thereof 湖南辰砾新材料有限公司 2018-10-16 CN claimed
CN-1890253-A Process for preparing ortho-metalated and ortho-substituted aromatic compounds SOLVIAS AG (CH) 2007-01-03 CN claimed
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2023-10-26 US disclosed
CN-108659534-A Building template material and preparation method thereof 湖南辰砾新材料有限公司 2018-10-16 CN disclosed
CN-105754099-B Composition and polymer 旭化成株式会社 2018-09-18 CN disclosed
CN-103502315-B Composition and polymer 旭化成株式会社 2016-08-17 CN disclosed
CN-105754099-A Composition and polymer 旭化成株式会社 2016-07-13 CN disclosed
WO-2016011107-A2 TRANSITION METAL-BASED SELECTIVE FUNCTIONALIZATION OF CHALCOGENS IN BIOMOLECULES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-21 WO disclosed
US-9082990-B2 Complex compounds having a ligand containing an N donor and a P donor and the use thereof in the opto-electronic field MERCK PATENT GMBH (DE) 2015-07-14 US disclosed
CN-103328435-B Process for producing aromatic amide carboxylic acid derivative MITSUI CHEMICALS AGRO INC 2015-07-01 CN disclosed
US-8981086-B2 Phosphine-ligated palladium sulfonate palladacycles MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-03-17 US disclosed
WO-1997040000-A1 PROCESSES FOR PRODUCING HYDROXYALDEHYDES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-10-30 WO disclosed
EP-0666255-B1 Process for the preparation of vitamin A and intermediates RHONE POULENC NUTRITION ANIMAL (FR) 1997-10-22 EP disclosed
US-5637779-A CONDENSATING ETHYNYL-B-IONOL WITH AN ACETAL IN PRESENCE OF A COPPER CATALYST AND A BASE; HYDROGENATING; FORMING RETINOL;REDUCTION RHONE-POULENC NUTRITION ANIMALE (FR) 1997-06-10 US disclosed
WO-1997014668-A1 OXIDATION OF ALDEHYDES TO CARBOXYLIC ACIDS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-04-24 WO disclosed
EP-0666255-A1 Process for the preparation of vitamin A and intermediates RHONE-POULENC NUTRITION ANIMALE (FR) 1995-08-09 EP disclosed
EP-0136210-B1 CHIRAL PHOSPHORUS LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE CATALYSIS OF ENANTIOSELECTIVE SYNTHESIS REACTIONS NORSOLOR S.A. (FR) 1989-08-16 EP disclosed
EP-0136210-A1 Chiral phosphorus ligands, process for their preparation and their use in the catalysis of enantioselective synthesis reactions NORSOLOR S.A. (FR) 1985-04-03 EP disclosed
US-4469886-A PALLADIUM CATALYST HAVING PHOSPHOAMINE LIGAND THE STANDARD OIL COMPANY (US) 1984-09-04 US disclosed
EP-0052419-A1 Process for the selective hydrocarboxylation of propylene to isobutyric acid THE STANDARD OIL COMPANY (US) 1982-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 IKZF1, IKZF3, IKZF2 ALDH1A1 4344/4885MAPT 1369/4885GAA 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.